【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Pomalyst/ Imnovid
04.1.2 Revlimid
04.1.3 Zometa
04.1.4 Doxil/Caelyx
04.1.5 Thalomid/ Thalidomide Celgene
04.1.6 Kyprolis
04.1.7 Mozobil
04.1.8 Velcade
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding Multiple Myeloma
07.2 Pathophysiology
07.3 Epidemiology
07.4 Diagnosis
07.5 Staging
07.6 Management
07.7 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10.Market Segmentation by Dosage Form
10.1 Solid
10.2 Liquid
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Pipeline Portfolio
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Celgene
20.2.2 Johnson & Johnson
20.2.3 Novartis
20.2.4 Onyx
20.2.5 Sanofi
20.2.6 Takeda Pharmaceutical
20.3 Other and Future Prominent Vendors
21.Key Vendor Analysis
21.1 Celgene
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Strategy
21.1.4 Business Segmentation by Revenue
21.1.5 Sales by Geography
21.1.6 Key Information
21.1.7 SWOT Analysis
21.2 Johnson & Johnson
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Novartis
21.3.1 Key Facts
21.3.2 Business Description
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Sales by Geography
21.3.7 Business Strategy
21.3.8 Key Developments
21.3.9 SWOT Analysis
21.4 Onyx Pharmaceuticals
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Marketed Products
21.4.4 Geographical Segmentation
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Sanofi
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
21.6 Takeda Pharmaceutical
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Pathophysiology of Multiple Myeloma
Exhibit 3: Indicators of Multiple Myeloma
Exhibit 4: Laboratory Tests to Identify Multiple Myeloma
Exhibit 5: Diagnosis of Multiple Myeloma
Exhibit 6: Staging of Multiple Myeloma
Exhibit 7: Management of Multiple Myeloma
Exhibit 8: Induction Therapy Recommendations for the Transplant Eligible Candidates
Exhibit 9: Maintenance Therapy for the Candidates with Multiple Myeloma
Exhibit 10: Supportive Therapy for the Candidates with Multiple Myeloma
Exhibit 11: Estimated Expenditure for the Four Type of Treatment Regimens for Multiple Myeloma in the US
Exhibit 12: Snapshot of the Economic Burden of Multiple Myeloma
Exhibit 13: Snapshot of Global Multiple Myeloma Drugs Market 2014
Exhibit 14: Global Multiple Myeloma Drugs Market 2014-2019 (US$ million)
Exhibit 15: Global Multiple Myeloma Drugs Market Segmentation By Route Of Administration
Exhibit 16: Global Multiple Myeloma Drugs Market Segmentation by Route of Administration 2014
Exhibit 17: Global Multiple Myeloma Drugs Market Segmentation by Dosage Form
Exhibit 18: Global Multiple Myeloma Drugs Market Segmentation by Dosage Form 2014
Exhibit 19: Global Multiple Myeloma Drugs Market by Geographical Segmentation 2014
Exhibit 20: Buying Criteria of Global Multiple Myeloma Drugs Market 2014
Exhibit 21: Growth Drivers of the Global Multiple Myeloma Drugs Market
Exhibit 22: Drivers and their Impact on the Key Customer Category of Global Multiple Myeloma Drugs Market 2014
Exhibit 23: Drivers and their Impact on the Geographies of Global Multiple Myeloma Drugs Market 2014
Exhibit 24: Challenges of the Global Multiple Myeloma Drugs Market
Exhibit 25: Trends of the Global Multiple Myeloma Drugs Market
Exhibit 26: Phase III Pipeline Molecules for Multiple Myeloma
Exhibit 27: Global Multiple Myeloma Drugs Market Share Analysis 2014
Exhibit 28: Sales Forecast of Pomalyst 2014-2018 (US$ million)
Exhibit 29: YoY Sales Comparison of Revlimid 2007-2013 (US$ million)
Exhibit 30: Sales Forecast of Revlimid 2014-2018 (US$ million)
Exhibit 31: YoY Sales Comparison of Thalomid 2007-2013 (US$ million)
Exhibit 32: Sales Forecast of Thalomid 2014-2018 (US$ million)
Exhibit 33: YoY Sales Comparison of Velcade outside the US 2008-2013 (US$ million)
Exhibit 34: Sales Comparison of Zometa in the US and ROW 2007-2013 (US$ million)
Exhibit 35: Global YoY Sales Comparison of Zometa 2007-2013 (US$ million)
Exhibit 36: YoY Sales Comparison of Zometa in the US 2007-2013 (US$ million)
Exhibit 37: YoY Sales Comparison of Zometa in ROW 2007-2013 (US$ million)
Exhibit 38: Sales Forecast of Kyprolis 2014-2018 (US$ million)
Exhibit 39: Global YoY Sales Comparison of Mozobil 2007-2013 (US$ million)
Exhibit 40: Global YoY Sales Comparison of Velcade in Japan 2009-2013 (US$ million)
Exhibit 41: Sales Forecast of Velcade 2014-2018 (US$ million)
Exhibit 42: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 43: Celgene: Sales by Geography 2013
Exhibit 44: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 45: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 46: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 47: Novartis AG: Business Segmentation
Exhibit 48: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 49: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 50: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 51: Onyx Pharmaceuticals: Marketed Products
Exhibit 52: Onyx Pharmaceuticals: Geographical Segmentation
Exhibit 53: Sanofi: Business Segmentation by Revenue 2013
Exhibit 54: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 55: Sanofi: Geographical Segmentation by Revenue 2013
Exhibit 56: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 57: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013 (US$ million)
Exhibit 58: Takeda Pharmaceuticals: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：多発性骨髄腫治療薬の世界市場■ 英文：Global Multiple Myeloma Drugs Market 2015-2019
■ 発行日：2014年12月3日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4753
■ 調査対象地域：グローバル
- 血栓症治療薬の世界市場2019-2023About this market Sedentary lifestyle is resulting in an increase in the number of thrombosis cases. The increase in sedentary lifestyle is leading to the rise in the prevalence of obesity across the world, thus increasing the risk of thrombosis. Technavio’s analysts have predicted that the thrombosis drugs market will register a CAGR of more than 9% by 2023. Market Overview Growing awareness of c …
- ドア及び窓オートメーションの世界市場：オペレーター、センサー・感知器、アクセス制御システム、コントロールパネル、スイッチThe door and window automation market was valued at USD 11.48 Billion in 2015 and is expected to reach USD 17.76 Billion by 2022, at a CAGR of 6.2% between 2016 and 2022. The door and window automation market is expected to register a shipment of 20.6 million units in 2022, growing at a CAGR of 7.9% between 2016 and 2022. Easy accessibility for elderly and disabled people is one of the major drive …
- 世界のFTTx市場データThe bundle World FTTx market includes two deliverables: 1. A report analysing the developments in FTTx markets up to 2018. It presents a geographical panorama of FTTx access solutions in Europe, Asia, North America, Latin America, Middle East & Africa. It also includes an overview of the major world leaders as well as a panorama of the ultrafast broadband markets: Services and tariffs, ultrafast b …
- 耐熱性繊維の世界市場：アラミド繊維、セラミック繊維、バサルト繊維High temperature fibers are advanced high-performance fibers that have high load-bearing capacity with excellent resistance to thermal and flame. Owing to these unique properties, high temperature fibers find applications in security & protection, aerospace, automotive, industrial, and electrical & electronics, and other sectors. The high temperature fibers market size, in terms of value, is proje …
- 世界の軍事用電気光学式赤外線システム市場動向（2014-2018）About Military Electro-optic Infrared Systems EO/IR systems are one of the important systems used by the militaries. EO/IR systems find its uses in various technologies which is positioned on target accordingly. Target intentionality decides the preference of the spectral bands. For instance, missile launch detection system relies on the exhaust of the missile, which yields large radiation in the …
- 経腸栄養製剤の世界市場：高分子製剤、単量体製剤、疾患特異的製剤The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. On the other h …
- Rappahannock Electric Cooperative：発電所及びSWOT分析2013Rappahannock Electric Cooperative - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - …
- グローバルセイボリースナック 市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global savory snacks market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global savory snacks market throughout the month. Additionally, the report provides an overview of all th …
- 医療シミュレーション装置・サービスの世界市場：患者シミュレーター、手術シミュレーター、血管内治療シミュレーター、超音波シミュレーター等The global healthcare/medical simulation market is expected to grow at a lucrative CAGR of 19.1% during the forecast period of 2014 to 2019. Increasing focus on training of medical practitioners, rising healthcare costs, growing focus on patient safety, consolidation of the manufacturers, and rising demand for minimally invasive technologies are expected to drive the growth of the global healthcar …
- ソフトウェアテストの世界市場2017-2021About Software Testing Software testing is a process to validate the different components of system and application software to detect errors in the development of high-quality software products. The software testing process follows the software testing life cycle (STLC) protocols to test the validity of software products. Software testing tools, solutions, and services are subscribed by software …
- 学校事務ソフトウェアの世界市場2015-2019The growing demand for analytical applications in the education sector drives the global school administrative software market. Technavio market research analysts predict the global school administrative software market to grow at a CAGR of over 10% until 2019. Like many business industries, the education market has begun to use data science to improve its operations. Business entities use big dat …
- 世界のコバルト市場動向（2014-2018）TechNavio's analysts forecast the Global Cobalt market to grow at a CAGR of 6.05 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for cobalt from the Battery Chemicals industry. The Global Cobalt market has also been witnessing the supply constraints of cobalt leading to high prices. However, the cobalt supply challenges could pos …
- 乳癌治療用モノクローナル抗体の世界市場Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and efficacy levels. They have found that some receptors have overexpressed in cancerous cells due to which they …
- Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Vitreo Retinal Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Vitreo Retinal Surgery Devices market in the BRICS countries. The report provides value ($m), volume (units) and aver …
- 熱伝導材料の世界市場：グリース、接着剤、テープ、フィルム、填隙剤、金属TIM、相変化材料The report on TIMs captures its global market size by volume and value. This market is growing at a rapid pace in APAC and North America. The demand for TIMs is driven by the following factors: • LED is currently replacing the less energy efficient fluorescent lightings. However LED lights have some inherent physical contradictions. On one hand the LED current should get high to generate desired l …
